Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.Journal of Virology|February 14, 2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman PrimatesKevin O Saunders, Sampa Santra, Robert Parks, et al.Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.Cell Reports. Medicine|March 22, 2021
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionArunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.Science Translational Medicine|May 6, 2011
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in MonkeysNorman L Letvin, Srinivas S Rao, David C Montefiori, et al.Journal of Virology|April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostSandrine L Hulot, Bette Korber, Elena E Giorgi, et al.Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.Nature Communications|June 9, 2017
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challengeTodd Bradley, Justin Pollara, Sampa Santra, et al.Pageof 4